One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...
Pfizer CEO Albert Bourla on Monday flagged issues with the leadership of the U. Food and Drug Administration's vaccine ...
Good morning. What happens to an organization after it achieves a moonshot? That has been Albert Bourla’s reality, post-COVID. As the CEO of Pfizer, a company he first joined in 1993, Bourla—a ...
Hosted on MSN
Pfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
As the CEO of Pfizer, Albert Bourla led the team behind one of the most consequential medical breakthroughs of the modern era: the COVID-19 vaccine that saved millions of lives. Yet the leadership ...
Hosted on MSN
Pfizer CEO eyes big push towards obesity drug development in 2026 after $10B Metsera acquisition
Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. The company purchased Metsera in November for up to $10 billion to reignite its ...
Pfizer CEO Albert Bourla says he used extreme team-motivating tactics to meet seemingly impossible deadlines during the COVID-19 pandemic. Specifically, his team was tasked with creating a vaccine to ...
By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results